© 2022 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#Gilead Sciences

Morehouse School of Medicine in Atlanta

$4.5M Joint Effort to Improve Black HIV Care in Three Southern Cities

Gilead Sciences, the Morehouse School of Medicine and Xavier University boost HIV care for Black Americans in a COVID-impacted South.

$24M in Gilead Grants to End HIV Where COVID-19 Created Barriers

Gilead Sciences’ “Zeroing In” program helps 116 grantees boost HIV innovation, education and outreach in marginalized communities.
Remdesivir production.

FDA Approves Remdesivir for Hospitalized COVID-19 Patients

The antiviral drug is the first treatment for the new coronavirus to be approved in United States.
Downloadable infographics about NHAAD

National HIV/AIDS and Aging Awareness Day 2020

Nine key findings from a survey of HIV-positive people 50 and older. Plus: A special report on aging with HIV during COVID-19.
Remdesivir, an experimental drug being studied as a treatment for COVID-19

Remdesivir Shows Promise for COVID-19, but Not a Game Changer

FDA grants emergency use authorization, but randomized clinical trials of the antiviral drug show mixed results.

“We Are Seeing Few Cases of HIV-Positive People With Severe COVID-19”

As a result, researchers in Spain are testing whether HIV med Truvada, often used as PrEP, can also prevent COVID-19.

Supply of Our HIV and Hepatitis Meds Is Secure, Says Gilead

The assurance arrives as the pharma giant cuts off most emergency access to remdesivir, a potential COVID-19 treatment.

HIV Drugmaker Tests a Possible Treatment for New Coronavirus

Gilead Sciences is giving its antiviral remdesivir to nearly 1,000 people as part of two clinical trials.
Advertisement

COVID Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

COVID Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.